Support Our Personalized Oncology Investment Cycle

Our 2024 Breast Cancer investment Cycle has concluded with our investment in Veana Therapeutics, the fifth company in our growing portfolio.

Our next investment cycle targets Personalized Oncology: Innovations that tailor cancer care to each patient, including personalized therapies, management, diagnostics, and decision support solutions utilizing AI/ML and advanced analytics. This approach optimizes therapeutic strategies, enhances treatment efficacy, and improves patient outcomes and quality of life.

To join us in supporting cancer innovation, complete the form below and we’ll send you more information about how to become an investor in Cancer Fund I, LLC.